<VariationArchive RecordType="classified" VariationID="966299" VariationName="NM_000243.3(MEFV):c.265del (p.Ala89fs)" VariationType="Deletion" Accession="VCV000966299" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-07-16" MostRecentSubmission="2020-07-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="957746" VariationID="966299">
      <GeneList>
        <Gene Symbol="MEFV" FullName="MEFV innate immuity regulator, pyrin" GeneID="4210" HGNC_ID="HGNC:6998" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3242027" stop="3256633" display_start="3242027" display_stop="3256633" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3292027" stop="3306626" display_start="3292027" display_stop="3306626" Strand="-" />
          </Location>
          <OMIM>608107</OMIM>
          <Haploinsufficiency last_evaluated="2018-08-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEFV">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-08-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEFV">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000243.3(MEFV):c.265del (p.Ala89fs)</Name>
      <CanonicalSPDI>NC_000016.10:3256322:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="3256323" stop="3256323" display_start="3256323" display_stop="3256323" variantLength="1" positionVCF="3256322" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="3306323" stop="3306323" display_start="3306323" display_stop="3306323" variantLength="1" positionVCF="3306322" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A89fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_190" sequenceAccession="LRG_190">
            <Expression>LRG_190:g.5305del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_190t1" sequenceAccession="LRG_190t1">
            <Expression>LRG_190t1:c.265del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.3256325del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.3256325del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.3306325del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.3306325del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007871.1" sequenceAccession="NG_007871" sequenceVersion="1" change="g.5305del">
            <Expression>NG_007871.1:g.5305del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000243.3" sequenceAccession="NM_000243" sequenceVersion="3" change="c.265del" MANESelect="true">
            <Expression>NM_000243.3:c.265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000234.1" sequenceAccession="NP_000234" sequenceVersion="1" change="p.Ala89fs">
            <Expression>NP_000234.1:p.Ala89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001198536.2" sequenceAccession="NM_001198536" sequenceVersion="2" change="c.265del">
            <Expression>NM_001198536.2:c.265del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001185465.2" sequenceAccession="NP_001185465" sequenceVersion="2" change="p.Ala89fs">
            <Expression>NP_001185465.2:p.Ala89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1959114278" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000243.3(MEFV):c.265del (p.Ala89fs) AND Familial Mediterranean fever" Accession="RCV001240947" Version="1">
        <ClassifiedConditionList TraitSetID="647">
          <ClassifiedCondition DB="MedGen" ID="C0031069">Familial Mediterranean fever</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2020-07-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="647" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1273" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Periodic peritonitis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Benign paroxysmal peritonitis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial Mediterranean fever</ElementValue>
                <XRef ID="Familial+Mediterranean+fever/2756" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018088" DB="MONDO" />
                <XRef ID="12579009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYSEROSITIS, FAMILIAL PAROXYSMAL</ElementValue>
                <XRef Type="MIM" ID="249100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYSEROSITIS, RECURRENT</ElementValue>
                <XRef Type="MIM" ID="249100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FMF</ElementValue>
                <XRef Type="MIM" ID="249100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial Mediterranean fever (FMF) is divided into two phenotypes: type 1 and type 2. FMF type 1 is characterized by recurrent short episodes of inflammation and serositis including fever, peritonitis, synovitis, pleuritis, and, rarely, pericarditis and meningitis. The symptoms and severity vary among affected individuals, sometimes even among members of the same family. Amyloidosis, which can lead to renal failure, is the most severe complication, if untreated. FMF type 2 is characterized by amyloidosis as the first clinical manifestation of FMF in an otherwise asymptomatic individual.</Attribute>
                <XRef ID="NBK1227" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="274">gain of function</Attribute>
                <XRef ID="GTR000317682" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592341" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529138" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530037" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553553" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561788" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508733" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508985" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301405</ID>
                <ID Source="BookShelf">NBK1227</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_FamilialMediterraneanFever-enPro920.pdf</URL>
                <CitationText>Orphanet, Familial Mediterranean fever, 2013</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EMQN, 2012">
                <ID Source="pmc">3500529</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="SHARE, 2015">
                <ID Source="PubMed">25628446</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="Hentgen et al., 2013">
                <ID Source="PubMed">23742958</ID>
              </Citation>
              <XRef ID="342" DB="Orphanet" />
              <XRef ID="C0031069" DB="MedGen" />
              <XRef ID="MONDO:0018088" DB="MONDO" />
              <XRef Type="MIM" ID="249100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2749015" SubmissionDate="2020-02-06" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6596692|MedGen:C0031069" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001413933" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala89Glnfs*30) in the MEFV gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MEFV-related conditions. Loss-of-function variants in MEFV are known to be pathogenic (PMID: 23226472, 24469716, 28690860). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEFV" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000243.2:c.265del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Familial Mediterranean fever</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0031069" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2749015" TraitType="Disease" MappingType="Name" MappingValue="Familial Mediterranean fever" MappingRef="Preferred">
        <MedGen CUI="C0031069" Name="Familial Mediterranean fever" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

